ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Risk factors"

  • 2015 American Transplant Congress

    Clinical and Immunologic Risk Factors Associated With Donor-Specific Antibody (DSA) Formation Following Renal Transplantation

    C. Johnson,1 S. Park,1 J. Schiller.2

    1Department of Surgery, Medical College of Wisconsin, Milwaukee, WI; 2Blood Center of Wisconsin, Milwaukee, WI.

    Background: De novo DSA formation is emerging as an important risk factor for adverse graft outcomes following renal transplantation. Specific pretransplant risk factors for DSA…
  • 2015 American Transplant Congress

    The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function

    D. Felix,1 B. Astor,2 D. Hager,1 A. Djamali.2

    1Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI; 2Department of Medicine - Division of Nephrology, University of Wisconsin Hospital and Clinics, Madison, WI.

    The impact of selection of induction immunosuppression agent on incidence of delayed graft function (DGF) remains unclear. A total of 1,980 deceased donor kidney transplant…
  • 2015 American Transplant Congress

    South Asians Have a Higher Risk of PTDM and Death After Renal Transplantation

    D.-A. Moutzouris, L. Kozia, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    South Asians (SA) have a higher risk for cardiovascular disease and diabetes than the general population, but in renal transplant recipients, data are limited and…
  • 2015 American Transplant Congress

    Recreational and Lifestyle Infection Risks in Transplant Recipients

    R. Avery,1 D. Ostrander,1 S. Shoham,1 S. Alp,2 N. Lu,1 C. Cave,1 E. Kraus,3 K. Marr.1

    1Infectious Disease, Johns Hopkins, Baltimore, MD; 2Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey; 3Nephrology, Johns Hopkins, Baltimore, MD.

    Background: Counseling is commonly provided to transplant candidates and recipients concerning “strategies for safer living”, including ways to minimize infection risk.Methods: Patients enrolled in a…
  • 2015 American Transplant Congress

    Pre-Transplant Angiotensin Receptor II Type 1 Antibodies (AT1R) and Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) as Predictors of Post Transpalnt FSGS Recurrence

    A. Khalil, T. Tim, A. Sharfuddin, S. Doshi, M. Yaqub, D. Mishler, W. Goggins, M. Mujtaba.

    Indiana University school of Medicine-IU Health Transplant, Indianapolis, IN.

    Approximately 30% of renal transplant patients develop recurrence of FSGS in the first kidney allograft. AT1R is expressed on podocytes; its expression is elevated in…
  • 2015 American Transplant Congress

    Increased Length of Stay After Heart Transplant: What Are the Risk Factors?

    A. Velleca, M. Kittleson, N. Perry, J. Patel, F. Liou, S. Siddiqui, J. Rush, D. Ramzy, L. Czer, D. Chang, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Purpose: Initial hospital length of stay following heart transplant is variable. The longer the hospital stay, the increased cost related to the surgery. This will…
  • 2015 American Transplant Congress

    Does Pulmonary Rehabilitation Impact Frailty?

    C. Kennedy,1 P. Novotny,2 N. LeBrasseur,3 R. Wise,4 F. Sciurba,5 R. Benzo.1

    1Pulmonary and Critical Care, Mayo Clinic, Rochester, MN; 2Health Sciences Research-Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN; 3Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN; 4Pulmonary and Critical Care, Johns Hopkins, Baltimore, MD; 5Pulmonary, Allergy and Critical Care, University of Pittsburgh, Pittsburgh, PA.

    Purpose: Frailty is an emerging risk factor for morbidity and mortality in advanced lung disease and lung transplantation. Interventions to reduce frailty in this population…
  • 2015 American Transplant Congress

    Low Vitamin D Exposure Is Associated With Higher Risk of Infection in Renal Transplant Recipients

    L. Sacha,1 H. Kalluri,2 A. Ingemi,3 H. Johnson,4 D. Landsittel,5 M. Shullo,4 R. Venkataramanan.2,6

    1Department of Pharmacy, Saint Barnabas Medical Center, Livingston, NJ; 2Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA; 3Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA; 4Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA; 5Department of Medicine, University of Pittsburgh, Pittsburgh, PA; 6Starzl Transplant Institute, University of Pittsburgh, Pittsburgh, PA.

    PURPOSE: Vitamin D has multiple vital functions within the immune system. This study aims to assess the relationship between vitamin D exposure and the incidence…
  • 2015 American Transplant Congress

    New SRTR Risk-Adjustment Models for Adult Kidney Transplant Outcomes

    J. Snyder,1 N. Salkowski,1 D. Zaun,1 H. Xiong,1 S. Leppke,1 B. Thompson,1 D. Segev,1,2 L. Hunsicker,1 A. Israni,1 B. Kasiske.1

    1Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN; 2Johns Hopkins University, Baltimore, MD.

    Following a recommendation of the Consensus Conference on Transplant Program Quality and Surveillance, SRTR implemented a 3-year rolling cycle to rebuild the statistical models used…
  • 2015 American Transplant Congress

    The Higher MFI of De Novo Donor-Specific Anti-HLA Antibodies Is Correlated With Graft Fibrosis Progression in Living Donor Liver Transplantation

    Y. Fukasaku,1 R. Goto,1 S. Emoto,1 N. Kawamura,1 Y. Koshizuka,1 T. Takahashi,1 M. Ota,3 T. Aoyagi,1 K. Yamashita,2 A. Taketomi,1 T. Shimamura.3

    1Gastroenterological Surgery 1, Hokkaido University, Sapporo, Japan; 2Transplant Surgery, Hokkaido University, Sapporo, Japan; 3Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan.

    Background. It has been shown that the development of de novo donor-specific anti-HLA antibodies (DSA) is associated with poorer graft outcome in kidney transplantation. However…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences